Mechanistically, another study indicated that TRIM11 can destabilize Axin1 and promote its degradation via ubiquitination, resulting in the β-catenin pathway activation in gastric cancer cells and lymphoma cells [67,70]. The gene discussed is TRIM11; the disease is gastric cancer.